Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP945702.RAllKhnMc_vImXRqHAs9Z1NBNFuOWjq8DrZEhfcCDByi4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP945702.RAllKhnMc_vImXRqHAs9Z1NBNFuOWjq8DrZEhfcCDByi4130_assertion type Assertion NP945702.RAllKhnMc_vImXRqHAs9Z1NBNFuOWjq8DrZEhfcCDByi4130_head.
- NP945702.RAllKhnMc_vImXRqHAs9Z1NBNFuOWjq8DrZEhfcCDByi4130_assertion description "[The receptor tyrosine kinase MET is a prime target in clinical oncology due to its aberrant activation and involvement in the pathogenesis of a broad spectrum of malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945702.RAllKhnMc_vImXRqHAs9Z1NBNFuOWjq8DrZEhfcCDByi4130_provenance.
- NP945702.RAllKhnMc_vImXRqHAs9Z1NBNFuOWjq8DrZEhfcCDByi4130_assertion evidence source_evidence_literature NP945702.RAllKhnMc_vImXRqHAs9Z1NBNFuOWjq8DrZEhfcCDByi4130_provenance.
- NP945702.RAllKhnMc_vImXRqHAs9Z1NBNFuOWjq8DrZEhfcCDByi4130_assertion SIO_000772 24061647 NP945702.RAllKhnMc_vImXRqHAs9Z1NBNFuOWjq8DrZEhfcCDByi4130_provenance.
- NP945702.RAllKhnMc_vImXRqHAs9Z1NBNFuOWjq8DrZEhfcCDByi4130_assertion wasDerivedFrom befree-20150227 NP945702.RAllKhnMc_vImXRqHAs9Z1NBNFuOWjq8DrZEhfcCDByi4130_provenance.
- NP945702.RAllKhnMc_vImXRqHAs9Z1NBNFuOWjq8DrZEhfcCDByi4130_assertion wasGeneratedBy ECO_0000203 NP945702.RAllKhnMc_vImXRqHAs9Z1NBNFuOWjq8DrZEhfcCDByi4130_provenance.